[1]
D. P. Prabhudesai, “Efficacy and Safety of Levonadifloxacin in the Management of Community-Acquired Bacterial Pneumonia (CABP): Findings of a Retrospective, Real-World, Multi-centre Study”, ijirms, vol. 6, no. 12, pp. 919–925, Dec. 2021.